Applied Therapeutics/$APLT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Applied Therapeutics
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
Ticker
$APLT
Sector
Primary listing
Employees
32
Headquarters
Website
APLT Metrics
BasicAdvanced
$75M
-
-$0.48
1.97
-
Price and volume
Market cap
$75M
Beta
1.97
52-week high
$9.85
52-week low
$0.30
Average daily volume
940K
Financial strength
Current ratio
1.944
Quick ratio
1.714
Long term debt to equity
12.358
Total debt to equity
14.921
Profitability
EBITDA (TTM)
-111.388
Gross margin (TTM)
-36,497.52%
Net profit margin (TTM)
-55,982.64%
Operating margin (TTM)
-92,057.02%
Management effectiveness
Return on assets (TTM)
-84.32%
Return on equity (TTM)
-150.82%
Valuation
Price to revenue (TTM)
622.129
Price to book
4.23
Price to tangible book (TTM)
4.23
Price to free cash flow (TTM)
-0.82
Free cash flow yield (TTM)
-121.96%
Free cash flow per share (TTM)
-0.634
Growth
Revenue change (TTM)
-136.34%
Earnings per share change (TTM)
-65.29%
3-year earnings per share growth (CAGR)
-50.73%
What the Analysts think about APLT
Analyst ratings (Buy, Hold, Sell) for Applied Therapeutics stock.
APLT Financial Performance
Revenues and expenses
APLT Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Applied Therapeutics stock?
Applied Therapeutics (APLT) has a market cap of $75M as of September 03, 2025.
What is the P/E ratio for Applied Therapeutics stock?
The price to earnings (P/E) ratio for Applied Therapeutics (APLT) stock is 0 as of September 03, 2025.
Does Applied Therapeutics stock pay dividends?
No, Applied Therapeutics (APLT) stock does not pay dividends to its shareholders as of September 03, 2025.
When is the next Applied Therapeutics dividend payment date?
Applied Therapeutics (APLT) stock does not pay dividends to its shareholders.
What is the beta indicator for Applied Therapeutics?
Applied Therapeutics (APLT) has a beta rating of 1.97. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.